The Conversation (0)
Companies Agree to Asian Distribution/Supply Agreement for Migraine Agent
Oct. 23, 2013 12:30PM PST
Market NewsCoLucid Pharmaceuticals, Inc., and Ildong Pharmaceutical Co., Ltd. (KRX:000230) have entered into a distribution and supply agreement for Lasmiditan, an agent for acute migraines, in South Korea and Southeast Asia.
CoLucid Pharmaceuticals, Inc., and Ildong Pharmaceutical Co., Ltd. (KRX:000230) announced they have entered into a distribution and supply agreement for Lasmiditan, an agent for acute migraines, in South Korea and Southeast Asia.
As quoted in the press release:
“We are very happy to announce the collaboration with ILDONG. We look forward to working together with such a strong partner to bring Lasmiditan to the market to meet the many unmet needs of migraine sufferers,” said Thomas P. Mathers, CEO of CoLucid.